17-year-old Matt Pettit, an
enterprising high school senior, has helped support prostate cancer
research by designing reusable grocery bags with proceeds going to the
Prostate Cancer Foundation. Sign up to receive more information on how you can order the bags.
Study of Immunotherapy to Treat Advanced Prostate Cancer
BMS is conducting a Phase 3 trial using a novel immunotherapy agent in patients with metastatic CRPC that have received prior treatment with docetaxel. Ipilimumab (anti CTLA-4) plus radiotherapy will be compared to placebo plus radiotherapy in this study, to determine if ipilimumab prolongs survival in men who have metastatic CRPC.